Laleh Amiri-Kordestani

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 42

Top Topics

Renal Cell Carcinoma

Drug Administration

Metastatic Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Jaleh Fallah, Brian L Heiss, Hee-Koung Joeng, Chana Weinstock, Xin Gao, William F Pierce, Benjamin Chukwurah, Vishal Bhatnagar, Mallorie H Fiero, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel L Suzman
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mirat Shah, Hima Lingam, Xin Gao, Haley Gittleman, Mallorie H Fiero, Danielle Krol, Nikolett Biel, Tiffany K Ricks, Wentao Fu, Salaheldin Hamed, Fang Li, Jillian Jielin Sun, Jianghong Fan, Robert N Schuck, Manuela Grimstein, Liuya Tang, Shyam Kalavar, Abdelrahmman Abukhdeir, Anand Pathak, Soma Ghosh, Ilynn Bulatao, Amy Tilley, William F Pierce, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Paul Kluetz, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Xin Gao, Brian L Heiss, William F Maguire, Elaine Chang, Sundeep Agrawal, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel L Suzman
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jaleh Fallah, Jianjin Xu, Hee-Koung Joeng, Chana Weinstock, Brian L Heiss, William F Maguire, Xin Gao, Joyce Cheng, Elaine Chang, Sundeep Agrawal, Mallorie H Fiero, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations. JCO precision oncology 8 (2024)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Xin Gao, Brian L Heiss, William F Maguire, Elaine Chang, Sundeep Agrawal, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel L Suzman
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Xin Gao, Brian L Heiss, William F Maguire, Elaine Chang, Sundeep Agrawal, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel L Suzman
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Mirat Shah, Hima Lingam, Xin Gao, Haley Gittleman, Mallorie H Fiero, Danielle Krol, Nikolett Biel, Tiffany K Ricks, Wentao Fu, Salaheldin Hamed, Fang Li, Jillian Jielin Sun, Jianghong Fan, Robert N Schuck, Manuela Grimstein, Liuya Tang, Shyam Kalavar, Abdelrahmman Abukhdeir, Anand Pathak, Soma Ghosh, Ilynn Bulatao, Amy Tilley, William F Pierce, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Paul Kluetz, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michael H Brave, William F Maguire, Chana Weinstock, Hui Zhang, Xin Gao, Fang Li, Jingyu Yu, Wentao Fu, Hong Zhao, William F Pierce, Elaine Chang, Jeannette Dinin, Mallorie H Fiero, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Xin Gao, Brian L Heiss, William F Maguire, Elaine Chang, Sundeep Agrawal, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel L Suzman
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Asma Dilawari, James Buturla, Christy Osgood, Xin Gao, Wei Chen, Tiffany K Ricks, Timothy Schaefer, Sreedevi Avasarala, Francisca Reyes Turcu, Anand Pathak, Shyam Kalavar, Vishal Bhatnagar, Justin S Collazo, Nam Atiqur Rahman, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Paul Kluetz, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With PIK3CA / AKT1 / PTEN Alterations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mirat Shah, Hima Lingam, Xin Gao, Haley Gittleman, Mallorie H Fiero, Danielle Krol, Nikolett Biel, Tiffany K Ricks, Wentao Fu, Salaheldin Hamed, Fang Li, Jillian Jielin Sun, Jianghong Fan, Robert N Schuck, Manuela Grimstein, Liuya Tang, Shyam Kalavar, Abdelrahmman Abukhdeir, Anand Pathak, Soma Ghosh, Ilynn Bulatao, Amy Tilley, William F Pierce, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Paul Kluetz, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin Plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Jennifer J Gao, Christy L Osgood, Zhou Feng, Erik W Bloomquist, Shenghui Tang, C J George Chang, Tiffany K Ricks, Sherry C Hou, William F Pierce, Donna R Rivera, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Asma Dilawari, Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H Fiero, Ankit Shah, Salaheldin S Hamed, Junshan Qiu, Jingyu Yu, Wimolnut Manheng, Tiffany K Ricks, Rajan Pragani, Arulvathani Arudchandran, Paresma Patel, Shadia Zaman, Arpita Roy, Shyam Kalavar, Soma Ghosh, William F Pierce, Nam Atiqur Rahman, Shenghui Tang, Bronwyn D Mixter, Paul G Kluetz, Richard Pazdur, Laleh Amiri-Kordestani
FDA Approval Summary: Mirvetuximab soravtansine-gynx for FRα-positive, Platinum-Resistant Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Melanie E Royce, Flora Mulkey, Christy Osgood, Erik W Bloomquist, Laleh Amiri-Kordestani
US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Preeti Narayan, Asma Dilawari, Christy Osgood, Zhou Feng, Erik W Bloomquist, William F Pierce, Samina Jafri, Shyam Kalavar, Marina Kondratovich, Prakash Jha, Soma Ghosh, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik W Bloomquist, Mallorie H Fiero, Timothy Schaefer, Anand Pathak, Abdelrahmman Abukhdeir, Vishal Bhatnagar, Haw-Jyh Chiu, Tiffany Ricks, Christy John, Salaheldin Hamed, Christal Lee, William F Pierce, Shyam Kalavar, Reena Philip, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel Suzman
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jennifer K Litton, Meredith M Regan, Lajos Pusztai, Hope S Rugo, Sara M Tolaney, Elizabeth Garrett-Mayer, Laleh Amiri-Kordestani, Reva K Basho, Ana F Best, Jean-Francois Boileau, Carsten Denkert, Jared C Foster, Nadia Harbeck, Heather A Jacene, Tari A King, Ginny Mason, Ciara Catherine O'Sullivan, Tatiana M Prowell, Andrea L Richardson, Karla A Sepulveda, Mary Lou Smith, Judy A Tjoe, Gulisa Turashvili, Wendy A Woodward, Lynn Pearson Butler, Elena I Schwartz, Larissa A Korde
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik W Bloomquist, Mallorie H Fiero, Timothy Schaefer, Anand Pathak, Abdelrahmman Abukhdeir, Vishal Bhatnagar, Haw-Jyh Chiu, Tiffany Ricks, Christy John, Salaheldin Hamed, Christal Lee, William F Pierce, Shyam Kalavar, Reena Philip, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel Suzman
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (5) (2023)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik W Bloomquist, Mallorie H Fiero, Timothy Schaefer, Anand Pathak, Abdelrahmman Abukhdeir, Vishal Bhatnagar, Haw-Jyh Chiu, Tiffany Ricks, Christy John, Salaheldin Hamed, Christal Lee, William F Pierce, Shyam Kalavar, Reena Philip, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel Suzman
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (5) (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jeanne Fourie Zirkelbach, Mirat Shah, Jonathon Vallejo, Joyce Cheng, Amal Ayyoub, Jiang Liu, Rachel Hudson, Rajeshwari Sridhara, Gwynn Ison, Laleh Amiri-Kordestani, Shenghui Tang, Thomas Gwise, Atiqur Rahman, Richard Pazdur, Marc R Theoret
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (30) (2022)
Mirat Shah, Christy L Osgood, Anup K Amatya, Mallorie H Fiero, William F Pierce, Abhilasha Nair, Jonathan Herz, Kim J Robertson, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Melanie E Royce, Christy Osgood, Flora Mulkey, Erik Bloomquist, William F Pierce, Arpita Roy, Shyam Kalavar, Soma Ghosh, Reena Philip, Fatima Rizvi, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, Mallorie H Fiero, Sriram Subramaniam, Christy John, Wei Chen, Tiffany K Ricks, Gang Niu, Anthony Fotenos, Min Wang, Kelly Chiang, William F Pierce, Daniel L Suzman, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Amna Ibrahim, Paul G Kluetz
FDA Approval Summary: lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sara M Tolaney, Elizabeth Garrett-Mayer, Julia R White, Victoria S Blinder, Jared C Foster, Laleh Amiri-Kordestani, E Shelley Hwang, Judith M Bliss, Eileen Rakovitch, Jane Perlmutter, Patricia A Spears, Elizabeth Frank, Nadine M Tung, Anthony D Elias, David A Cameron, Neelima Denduluri, Ana F Best, Andrea Gombos, Lawrence Baizer, Lynn Pearson Butler, Elena Schwartz, Eric P Winer, Larissa A Korde
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Jeremy Mason, Yutao Gong, Laleh Amiri-Kordestani, Suparna Wedam, Jennifer J Gao, Tatiana M Prowell, Harpreet Singh, Anup Amatya, Shenghui Tang, Richard Pazdur, Peter Kuhn, Gideon M Blumenthal, Julia A Beaver
Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer. JCO clinical cancer informatics 5 (2021)